US Equity
GILD
— GILEAD SCIENCES, INC.Gilead Sciences is a biopharmaceutical company focused on developing and commercializing antiviral medicines, particularly for HIV, hepatitis, and COVID-19.
💰 Market cap: $162.05B📍 333 LAKESIDE DR, FOSTER CITY, CA, 94404-1147 US🏷️ Pharmaceuticals💵 Previous close: $129.31🔢 9,878 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $129.31 |
| 2026-07-23 | $130.86 |
| 2026-07-22 | $130.34 |
| 2026-07-21 | $130.28 |
| 2026-07-20 | $133.21 |
| 2026-07-17 | $134.28 |
| 2026-07-16 | $136.30 |
| 2026-07-15 | $131.70 |
| 2026-07-14 | $130.04 |
| 2026-07-13 | $131.40 |
| 2026-07-10 | $129.83 |
| 2026-07-09 | $134.84 |
| 2026-07-08 | $135.82 |
| 2026-07-07 | $136.36 |
| 2026-07-06 | $129.61 |
| 2026-07-02 | $131.27 |
| 2026-07-01 | $125.97 |
| 2026-06-30 | $126.34 |
| 2026-06-29 | $126.33 |
| 2026-06-26 | $127.88 |
| 2026-06-25 | $123.84 |
| 2026-06-24 | $125.16 |
| 2026-06-23 | $125.05 |
| 2026-06-22 | $124.87 |
| 2026-06-18 | $123.76 |
| 2026-06-17 | $125.45 |
| 2026-06-16 | $127.23 |
| 2026-06-15 | $124.30 |
| 2026-06-12 | $125.59 |
| 2026-06-11 | $125.87 |
| 2026-06-10 | $121.48 |
| 2026-06-09 | $125.50 |
| 2026-06-08 | $128.10 |
| 2026-06-05 | $129.16 |
| 2026-06-04 | $129.18 |
| 2026-06-03 | $128.99 |
| 2026-06-02 | $127.57 |
| 2026-06-01 | $131.10 |
| 2026-05-29 | $134.43 |
| 2026-05-28 | $136.22 |
| 2026-05-27 | $133.69 |
| 2026-05-26 | $133.73 |
| 2026-05-22 | $134.36 |
| 2026-05-21 | $130.50 |
| 2026-05-20 | $130.69 |
| 2026-05-19 | $130.50 |
| 2026-05-18 | $129.67 |
| 2026-05-15 | $129.58 |
| 2026-05-14 | $132.06 |
| 2026-05-13 | $133.05 |
| 2026-05-12 | $134.94 |
| 2026-05-11 | $133.52 |
| 2026-05-08 | $131.33 |
| 2026-05-07 | $134.06 |
| 2026-05-06 | $136.30 |
| 2026-05-05 | $133.48 |
| 2026-05-04 | $132.69 |
| 2026-05-01 | $131.65 |
| 2026-04-30 | $130.84 |
| 2026-04-29 | $128.84 |
| 2026-04-28 | $129.26 |